ANTM

Anthem Inc

Healthcare, Event Driven/Special Sit


Presented:02/03/2016
Price:$126.83
Cap:$33.99B
Current Price:$483.87
Cap:$112.20B

Presented

Date02/03/2016
Price$126.83
Market Cap$33.99B
Ent Value$53.23B
P/E Ratio13.59x
Book Value$89.02
Div Yield1.97%
Shares O/S268.00M
Ave Daily Vol2,012,679
Short Int3.61%

Current

Price$483.87
Market Cap$112.20B
Anthem, Inc. provides life, hospital and medical insurance plans. It offers a broad spectrum of network-based managed care health benefit plans to the large and small employer, individual, Medicaid and Medicare markets. The company also provides an array of specialty and other insurance products and services such as behavioral health benefit services, dental, vision, life and disability insurance benefits, radiology benefit management, analytics-driven personal health care guidance and long-term care insurance. It also provides services to the Federal Government in connection with the Federal Employee Program, or FEP, and various Medicare programs. The company operates through three segments: Commercial and Specialty Business, Government Business and Other. The Commercial and Specialty Business segment includes local group, national accounts, and individual and specialty businesses. The Government Business segment includes medi care and medic aid businesses, national government services and services provided to the federal government in connection with FEP. The Other segment includes other businesses that do not meet the quantitative thresholds for an operating segment as defined by financial accounting standards board guidance, as well as corporate expenses not allocated to the other reportable segments. The company was founded on November 30, 2004 and is headquartered in Indianapolis, IN.

Please note, this idea was updated on 06/13/2013 and can be read here: Long - Anthem Inc.

Publicly traded companies mentioned herein: Aetna Inc (AET), Anthem Inc (ANTM), Cigna Corp (CI), CVS Health Corporation (CVS), Express Scripts Holding Company (ESRX), Humana Inc (HUM)

Highlights

Shares of Blue Cross Blue Shield plan provider Anthem (ANTM) represent an attractive value at ~$125, in the presenter’s opinion. There are three components to the bullish thesis, including the “standalone” value, the value of a combined ANTM/ Cigna, and the upside to both scenarios from the re-pricing of the pharmacy benefits contract with Express Scripts. He sees the potential for at least 45% upside for shareholders over the next 12-18 months based on the standalone case, and 70%+ upside if the deal goes through and the multiple expands.

  • Signing up and creating account with us unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

  • Signing up and creating account with us unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Request access to DeMatteo Research for full access

Request Access

Already have an account?

Idea Discussion

Commentor 1 - 2 weeks ago

Signing up and creating account with us, unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Commentor 1 - 2 weeks ago

Signing up and creating account with us, unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Idea Discussions display submitted commentary from our investor community.

To read and participate in the discussion with the presenter and investor base, request access to DeMatteo

Request Access

Already have an account?

An error occurred loading this content. Try again later or contact us.